DAPK1 and neoplasm: DAPK1 loss was associated with high-grade tumor budding (50% of evaluated tumors) demonstrating that every second HPF of DAPK1 negative tumors was given a high-grade score whereas 89% of all HCT116 wildtype tumors were low-grade budders (Fig. 2f).